• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INVA

INVA

Innoviva, Inc.

NASDAQHealthcareBiotechnologyUS

USD21.70

+0.35 (+1.64%)

Rating:A+

Company Profile

CEO

Pavel Raifeld

IPO Date

2004-10-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$21.41

Prev. Close

$21.35

Day Low

$21.29

Day High

$21.89

52W Low

$16.52

52W High

$25.15

Market Cap

$1.60B

Volume

0.91M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

23.0%

Avg Negative

33.6%

Avg Neutral

43.3%

News Feed

GSK Exits Respiratory Partner Innoviva In $392M Deal

Benzinga·5/20/2021·↑ positive

Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva

PRNewsWire·3/17/2021·↑ positive

Moving Average Crossover Alert: Innoviva

Zacks Investment Research·3/8/2021·↓ negative

Buying Back In To Innoviva

Seeking Alpha·2/22/2021·↑ positive

Innoviva: Q4 Earnings Insights

Benzinga·2/3/2021·↑ positive

Should Value Investors Buy Innoviva (INVA) Stock?

Zacks Investment Research·1/1/2021·↑ positive

Top Ranked Value Stocks to Buy for December 24th

Zacks Investment Research·12/24/2020·↑ positive

Innoviva Can Offer 25% Upside From Current Levels

Forbes·12/24/2020·↓ negative

Stock market crash/cheap shares: I think this FTSE 100 stock is a crazy bargain buy!

https://www.fool.co.uk·10/22/2020·↓ negative

European cities plead for more flu shots as winter looms, pandemic rages

investing·10/22/2020·↓ negative